<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: ARIA News</title><copyright>Copyright (c) 2013 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=aria</link><description>Latest Financial News for ARIAD Pharmaceuticals, Inc.</description><language>en-US</language><lastBuildDate>Sat, 15 Jun 2013 22:30:20 GMT</lastBuildDate><image><url>http://l.yimg.com/a/i/brand/purplelogo/uh/us/fin.gif</url><title>Yahoo! Finance: ARIA News</title><link>http://finance.yahoo.com/q/h?s=aria</link><width>144</width><height>45</height></image><item><title>1 Thing You Always Wanted to Know About Drugs (but Were Afraid to Ask)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=13av8sdk3/*http://www.fool.com/investing/general/2013/06/14/1-thing-you-always-wanted-to-know-about-drugs-bu-2.aspx?source=eogyholnk0000001</link><description></description><guid isPermaLink="false">yahoo_finance/3504050616</guid><pubDate>Sat, 15 Jun 2013 22:30:20 GMT</pubDate></item><item><title>ARIAD Announces Webcast of Its Annual Shareholders Meeting</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125vhkpdo/*http://www.noodls.com/view/ACADDAA25D199A480BB20D74AB54601BBB242A75</link><description>[at noodls] - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 13, 2013-- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that its Annual Meeting of Stockholders will be webcast live on June 20, 2013 and can be accessed ...</description><guid isPermaLink="false">yahoo_finance/2170717970</guid><pubDate>Thu, 13 Jun 2013 13:32:42 GMT</pubDate></item><item><title>ARIAD Announces Webcast of Its Annual Shareholders Meeting</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/ariad-announces-webcast-annual-shareholders-113500545.html</link><description>[Business Wire] - ARIAD Pharmaceuticals, Inc. today announced that its Annual Meeting of Stockholders will be webcast live on June 20, 2013 and can be accessed by visiting the investo</description><guid isPermaLink="false">yahoo_finance/2102471054</guid><pubDate>Thu, 13 Jun 2013 11:35:00 GMT</pubDate></item><item><title>Ariad Pharmaceuticals Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-11-2013 02:40 PM</title><link>http://us.rd.yahoo.com/finance/external/xtrsa/rss/SIG=14rsculsn/*http://seekingalpha.com/article/1495622-ariad-pharmaceuticals-inc-presents-at-goldman-sachs-34th-annual-global-healthcare-conference-jun-11-2013-02-40-pm?source=yahoo</link><description>[at Seeking Alpha] - Ariad Pharmaceuticals Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-11-2013 02:40 PM</description><guid isPermaLink="false">yahoo_finance/1590400254</guid><pubDate>Wed, 12 Jun 2013 00:40:07 GMT</pubDate></item><item><title>4 Healthcare Stock Stories For Thursday Inspection</title><link>http://us.rd.yahoo.com/finance/external/xwscheats/rss/SIG=12tfkte4h/*http://wallstcheatsheet.com/stocks/4-healthcare-stock-stories-for-thursday-inspection.html/?ref=YF</link><description></description><guid isPermaLink="false">yahoo_finance/483600405</guid><pubDate>Tue, 11 Jun 2013 22:31:08 GMT</pubDate></item><item><title>Ash Stevens to Manufacture Ponatinib API</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/ash-stevens-manufacture-ponatinib-api-143000643.html</link><description>[Marketwired] - Ash Stevens, Inc. , a leading provider of global contract pharmaceutical drug substance development and API manufacturing services, announces the U.S. Food and Drug Administration has approved ASI&apos;s manufacturing ...</description><guid isPermaLink="false">yahoo_finance/1402423207</guid><pubDate>Tue, 11 Jun 2013 14:30:00 GMT</pubDate></item><item><title>ARIAD Announces Initiation of Phase 2 Trial of Ponatinib in Patients with Gastrointestinal Stromal Tumors</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1259v5lq8/*http://www.noodls.com/view/C1FC268D8B843E7C9A6FF20BB31913DC5E959E17</link><description>[at noodls] - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 11, 2013-- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the initiation of the Phase 2 trial of Iclusig® (ponatinib)in adult patients with metastatic ...</description><guid isPermaLink="false">yahoo_finance/1653136093</guid><pubDate>Tue, 11 Jun 2013 13:39:15 GMT</pubDate></item><item><title>ARIAD Announces Initiation of Phase 2 Trial of Ponatinib in Patients with Gastrointestinal Stromal Tumors</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/ariad-announces-initiation-phase-2-113500879.html</link><description>[Business Wire] - ARIAD Pharmaceuticals, Inc. today announced the initiation of the Phase 2 trial of Iclusig® in adult patients with metastatic and/or unresectable gastrointestinal stromal tumors .</description><guid isPermaLink="false">yahoo_finance/1507526129</guid><pubDate>Tue, 11 Jun 2013 11:35:00 GMT</pubDate></item><item><title>Ariad dips as analyst lowers lung cancer drug view</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/ariad-dips-analyst-lowers-lung-191150075--finance.html</link><description></description><guid isPermaLink="false">yahoo_finance/482865879</guid><pubDate>Mon, 10 Jun 2013 19:11:50 GMT</pubDate></item><item><title>Ariad dips as analyst lowers lung cancer drug view</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/ariad-dips-analyst-lowers-lung-191150935.html</link><description></description><guid isPermaLink="false">yahoo_finance/485727434</guid><pubDate>Mon, 10 Jun 2013 19:11:50 GMT</pubDate></item><item><title>Trader bets on floor under Ariad Pharma</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/trader-bets-floor-ariad-pharma-163712439.html</link><description></description><guid isPermaLink="false">yahoo_finance/1623489039</guid><pubDate>Fri, 07 Jun 2013 16:37:12 GMT</pubDate></item><item><title>ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/130604/aria8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3357968609</guid><pubDate>Tue, 04 Jun 2013 13:31:24 GMT</pubDate></item><item><title>ARIAD to Present at Upcoming Investor Conferences</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/ariad-present-upcoming-investor-conferences-113000906.html</link><description>[Business Wire] - ARIAD Pharmaceuticals, Inc. today announced that it will provide an overview of the Company’s business at two upcoming investor conferences being held next week:</description><guid isPermaLink="false">yahoo_finance/1770931418</guid><pubDate>Tue, 04 Jun 2013 11:30:00 GMT</pubDate></item><item><title>Why Ariad&apos;s Iclusig Is A Potential Blockbuster</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12o0ghouc/*http://seekingalpha.com/article/1477891-why-ariad-s-iclusig-is-a-potential-blockbuster?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/4022878627</guid><pubDate>Mon, 03 Jun 2013 20:24:55 GMT</pubDate></item><item><title>Ariad Pharmaceuticals Inc. - Shareholder/Analyst Call</title><link>http://us.rd.yahoo.com/finance/external/xtrsa/rss/SIG=12s2007hh/*http://seekingalpha.com/article/1477351-ariad-pharmaceuticals-inc-shareholder-analyst-call?source=yahoo</link><description>[at Seeking Alpha] - Ariad Pharmaceuticals Inc. - Shareholder/Analyst Call</description><guid isPermaLink="false">yahoo_finance/1463433813</guid><pubDate>Mon, 03 Jun 2013 18:10:08 GMT</pubDate></item><item><title>Scrappy Upstarts Aiming For Pfizer&apos;s Xalkori Market</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12t5b650t/*http://seekingalpha.com/article/1476131-scrappy-upstarts-aiming-for-pfizer-s-xalkori-market?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/3375675302</guid><pubDate>Mon, 03 Jun 2013 10:58:52 GMT</pubDate></item><item><title>ARIAD Announces Long-Term Durability-of-Response Data on Ponatinib from Ongoing Phase 1 Study</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/ariad-announces-long-term-durability-130000091.html</link><description>[Business Wire] - ARIAD Pharmaceuticals, Inc. today announced long-term durability-of-response data from its Phase 1 trial of Iclusig® in heavily pretreated patients with resistant or intolerant chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia .</description><guid isPermaLink="false">yahoo_finance/3521100499</guid><pubDate>Sun, 02 Jun 2013 13:00:00 GMT</pubDate></item><item><title>ARIAD Presents Updated Phase 1 Data on AP26113 in Patients with Non-Small Cell Lung Cancer</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/ariad-presents-updated-phase-1-130000049.html</link><description>[Business Wire] - ARIAD Pharmaceuticals, Inc. today announced updated clinical results on its investigational tyrosine kinase inhibitor , AP26113, in patients with advanced non-small cell lung cancer from an ongoing Phase 1/2 trial.</description><guid isPermaLink="false">yahoo_finance/2821285802</guid><pubDate>Sun, 02 Jun 2013 13:00:00 GMT</pubDate></item><item><title>ARIAD Presents Analysis of Cardiovascular Risk Profile of Patients from Pivotal PACE Trial of Iclusig® (Ponatinib)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/ariad-presents-analysis-cardiovascular-risk-130000727.html</link><description>[Business Wire] - ARIAD Pharmaceuticals, Inc. today announced results of evaluation of the cardiovascular risk profile of Philadelphia-positive leukemia patients treated with Iclusig® in the pivotal PACE trial.</description><guid isPermaLink="false">yahoo_finance/3841588466</guid><pubDate>Sat, 01 Jun 2013 13:00:00 GMT</pubDate></item><item><title>ASCO Investment Ideas</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12dvdtoa4/*http://www.fool.com/investing/general/2013/05/31/asco-investment-ideas.aspx?source=eogyholnk0000001</link><description></description><guid isPermaLink="false">yahoo_finance/1881703225</guid><pubDate>Sat, 01 Jun 2013 11:40:21 GMT</pubDate></item></channel></rss>